Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: Potential inhibition of angiogenesis

Clinical Cancer Research

Volumn 2, Issue 12, 1996, Pages 1969-1979

  Huang, Suyun ^a   Xie, Keping ^a   Bucana, Corazon D ^a   Ullrich, Stephen E ^a   Bar Eli, Menashe ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMETASTATIC AGENT; INTERLEUKIN 10;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MELANOMA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOGENICITY TESTS; COLLAGENASES; DOWN-REGULATION; ENDOTHELIAL GROWTH FACTORS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-6; LUNG NEOPLASMS; LYMPHOCYTES, TUMOR-INFILTRATING; LYMPHOKINES; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 9; MELANOMA; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030443062     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Fiorentino, D. F., Bond, M. W., and Mosmann, T. R. Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med., 170: 2081-2095, 1989.
2. Moore, K. W., Vieira, P., Fiorentino, D. F., Trounstine, M. L., Khan, T. A., and Mosmann, T. R. Homology of cytokine synthesis inhibitory factor (IL-10) 10 the Epstein-Barr virus gene BCRF1. Science (Washington DC), 248: 1230-1234, 1990.
3. Howard, M., and O'Garra, A. Biological properties of interleukin 10. Immunol. Today. 13: 198-200, 1992
4. Zlotnik, A., and Moore, K. W. Interleukin 10. Cytokine, 3: 366-379, 1991.
5. Florentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., and O'Garra, A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol., 146: 3444-3451, 1991.
6. Moore, K. W., O'Garra, A., de Waal Malefyt, R., Vieira, P., and Mosmann, T. R. Interleukin 10. Annu. Rev. Immunol., 11: 165-190, 1993.
7. Hsu, D-H., de Waal Malefyt, R., Fiorentino, D. F., Dang, M-N., Vieira, P., de Vries, J., Spits, H., Mosmann, T. R., and Moore, K. W. Expression of IL-10 activity by Epstein-Barr virus protein BCRF1. Science (Washington DC), 250: 830-832, 1990.
8. Hsu, D-H., Moore, K. W., and Spits, H. Differential effects of interleukin-4 and -10 on interleukin-2-induced interferon-γ synthesis and lymphokine-activated killer activity. Int. Immunol., 4: 563-569, 1992.
9. de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., and de Vries, J. E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med., 174: 1209-1220, 1991.
10. Bogdan, C., Vodovotz, Y., and Nathan, C. Macrophage deactivation by interleukin-10. J. Exp. Med., 174: 1549-1555, 1991.
11. Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., and O'Garra, A. IL-10 inhibits cytokine production by activated macrophages. J. Immunol., 147: 3815-3822, 1991.
12. Mertz, P. M., DeWitt, D. L., Stetler-Stevenson, W. G., and Wahl, L. M. Interleukin-10 suppression of monocyte prostaglandin H synthase-2 J Biol. Chem., 269: 21322-21329, 1994.
13. de Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M-G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H., and de Vries, J. E. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med., 174: 915-924, 1991.
14. Gazzinelli, R. T., Oswald, I. P., James, S. L , and Sher, A. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ-activated macrophages. J. Immunol., 148: 1792-1796, 1992.
15. Folkman, J., and Klagsbrun, M. Angiogenic factors. Science (Washington DC), 235: 442-447, 1987.
16. Rak, J. W., St. Croix, B. D., and Kerbel, R. S. Consequences of angiogenesis for tumor progression, metastasis and cancer therapy. Anticancer Drugs. 6: 3-18, 1995.
17. Richter, G., Kruger-Krasagakes, S., Hein, G., Huls, C., Schmitt, E., Diamanstein, T., and Blankenstein, T. Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration. Cancer Res., 53: 4134-4137, 1993.
18. Li, L., Price, J. E , Fan, D., Zhang, R. D., Bucana, C. D., and Fidler, I. J. Correlation of growth capacity of human tumor cells in hard agarose with their in vivo proliferauon capacity at specific metastatic sites. J. Natl. Cancer Inst., 81. 1406-1412, 1989.
19. Hart, I. R. Selection and characterization of an invasive variant of the B16 melanoma. Am. J. Pathol , 97: 587-600, 1979.
20. Giovarelli, M., Musiani, P., Modesti, A., Dellabona, P., Casorati, G., Allione, A., Consalvo, M., Cavallo, F., diPierro, F., De Giovanni, C., Musso, T., and Forni, G. Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory. J. Immunol., 55: 3112-3123, 1995.
21. Radinsky, R , Fidler, I J., Price, J. E., Esumi, N., Tsan, R., Petty, C. M., Bucana, C. D., and Bar-Eli, M. Terminal differentiation and apoptosis in experimental lung metastases of human osteogenic sarcoma cells by wild type p53. Oncogene, 9: 1877-1883, 1994.
22. Huang, S . Singh, R. K., Xie, K , Gutman, M., Berry, K. K., Bucana, C. D., Fidler, I. J., and Bar-Eli, M Expression of the JE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells. Cancer Immunol. Immunother., 39: 231-238, 1994.
23. Huang, S., Xie, K., Singh, R. K., Gutman, M., and Bar-Eli, M. Suppression of tumor growth and metastasis of marine renal adenocarcinoma by syngeneic fibroblasts genetically engineered to secrete the JE/MCP-1 cytokine. J. Interferon Cytokine Res., 15: 655-665, 1995.
24. Ullrich, S. E. Mechanism involved in the systemic suppression of antigen-presenting cell function by UV irradiation: keratinocyte-derived IL-10 modulates antigen-presenting cell function of splenic adherent cells. J. Immunol., 152: 3410-3416, 1994.
25. Luca, M., Hunt B., Bucana, C. D., Johnson, J. P., Fidler, I. J., and Bar-Eli, M. Direct correlation between MUC18 expression and metastatic potential of human melanoma cells. Melanoma Res., 3: 35-41, 1993.
26. Singh, R. K., Gutman, M., Reich, R., and Bar-Eli, M. Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8. Cancer Res., 55: 3669-3674, 1995
27. INK4/MTS-1) gene in human melanoma cells: relevance to tumor growth and metastasis. Oncogene. 11: 1399-1402, 1995.
28. Fort, R., Marty, L., Piechaczyh, M., Sabrouty, S. E., Dani, C., Jeanteur, R., and Blanchard, J. M. Various rat adult tissues express only major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res., 13: 1431-1442, 1985.
29. Xie, Q-W., Cho, H. J , Calaycay, J., Mumford, R. A., Swiderek, K. M., Lee, T. D., Ding, A., Troso, T., and Nathan, C. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science (Washington DC), 266: 225-228, 1992
30. Rogelj, S., Weinberg, R. A., Fanning, P., and Klagsbrun, M. Basic fibroblast growth factor fused to a signal peptide transforms cells. Nature (Lond.), 331: 173-175, 1988.
31. Fidler, I. J. Orthotopic implantation of human colon carcinomas into nude mice provides a valuable model for the biology and therapy of cancer. Cancer Metastasis Rev., 10: 229-243, 1991.
32. Austyn, J. M., and Gordon, S. F4/80, a monoclonal antibody directed specifically against the mouse macrophages. Eur. J. Immunol., 11: 805-815, 1981.
33. Anthony, F. W., Wheeler, T, Elcock, C. L., Pickett, M., and Thomas, E. J. Identification of a specific pattern of vascular endothehal growth factor mRNA expression in human placenta and cultured placental fibroblasts Placenta, 15. 557-561, 1994.
34. Houck, K. A., Leung, D. W., Rowland, A. M., Winer, J., and Ferrara, N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanism. J. Biol. Chem., 267: 26031-26037, 1992.
35. Mantovani, A., Botazzi, B., Colotta, F., Sozzani, S., and Ruco, L. The origin and function of tumor-associated macrophages. Immunol. Today, 13: 265-270, 1992.
36. Folkman, J. The role of angiogenesis, in tumor growth. Semin. Cancer Biol , 3: 65-71, 1992.
37. Sunderkotter, C., Steinbrink, K., Goebeler, M., Bhardwaj, R., and Sorg, C. Macrophages and angiogenesis. J. Leukocyte Biol., 55: 410-422, 1994.
38. Allione, A., Consalvo, M., Nanni, P., Lollini, P. L., Cavallo, F., Giovarelli, M., Forni, M., Forni, G. A., Colombo, M. P., Dellabona, P., Hock, H., Blankenstein, T., Rosenthal, F. M., Gansbacher, G., Bosco, M. C , Musso, T., Guesella, L , and Guido F. Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin-1, IL4, IL6, IL7, IL10, tumor necrosis factor α, granulocyte macrophage colony stimulating factor, and γ-interferon gene or admixed with conventional adjuvants. Cancer Res., 54: 6022-6026, 1994.
39. Polverini, P. J., and Leibovich, S. J. Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. Lab. Invest., 51: 635-642, 1984.
40. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S . Cao, Y., Helene Sage, E., and Folkman, J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 79: 315-328, 1994.
41. Kumar, R., Dong, Z., and Fidler, I. J. Differential regulation of metalloelastase activity in murine peritoneal macrophages by GM-CSF and M-CSF. J Immunol., in press, 1996.
42. Koch, A. E., Polverini, P. J., Kunkel, S. L., DiPietro, L. A., Elner, V. M., Elner, S. G., and Strieter, R. M. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science (Washington DC), 258: 1798-1801, 1992.
43. Lacey, S., Nicod, L. P., Chicheportiche, R., Welgus, H. G., and Dayer, J. M. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J. Clin. Invest., 96: 2304-2310, 1995.
44. Wang, P., Wu, P., Siegel, M. I., Egan, R. W., and Billah, M. M. Interleukin (EL)-10 inhibits nuclear factor K B (NF κ B) activation in human monocytes-IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J. Biol. Chem., 270: 9558-9563, 1995.
45. Kundu, N., Beath, L. T., Jackson, M. J., and Fulton, A. M. Antimetastatic and antitumor activities of interleukin-10 in a murine model of breast cancer. J. Natl. Cancer Inst., 88: 536-541, 1996.
46. Geng, Y., Gulbins, E., Altman, A., and Lotz, M. Monocyte deactivation by interleukin 10 via inhibition of tyrosine kinase activity and the Ras signaling pathway. Proc. Natl. Acad. Sci. USA, 91: 8602-8606, 1994.
47. Hibbs, J. B., Taintor, R. R., Jr., and Vavrin, Z. Macrophage cytotoxicity: role for L-arginine deaminase activity and amino nitrogen to nitrate. Science (Washington DC), 235: 473-476, 1987.
48. Stuehr, D. J., and Nathan, C. F. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169: 1543-1555, 1989.
49. Voest, E. E., Kenyan, B. M., O'Reilly, M. S., Truitt, G., D'Amato, R. J., and Folkman, J. Inhibition of angiogenesis in vivo by interleukin 12. J. Natl. Cancer Inst., 87: 581-586, 1995.
50. Kerbel, R. S., and Hawley, R. G. Interleukin 12: newest member of the antiangiogenic club. J. Natl. Cancer Inst., 87: 557-559, 1995.
51. D'Andrea, A., Aste-Amezaga, M., Valiante, N. M., Ma, X., Kubin, M., and Trinchieri, G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med., 178: 1041-1048, 1993.
52. Powrie, F., Menon, S . and Coffman, R. L. Interleukin 4 and interleukin 10 synergize to inhibit cell mediated immunity in vivo. Eur. J. Immunol., 23: 3043-3049, 1993.
53. Chernoff, A. E., Granowitz, E. V., Shapiro, L., Vannier, E., Lonnemann, G., Angel, J. B., Kennedy, J. S., Robson, A. R., Wolff, S. M., and Dinarello, C. A. A randomized, controlled trial of IL-10 in humans: inhibition of inflammatory cytokine production and immune response. J. Immunol., 154. 5492-5499, 1995
54. Huhn, R. D., Radwanski, E., O'Connell, S. M., Sturgill, M. G., Clarke, L., Cody, R. P., Affrine, M. B., and Cutler, D. L. Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers. Blood, 87: 699-705, 1996.